<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1" />
<meta http-equiv="Content-Style-Type" content="text/css" />
<link rel="stylesheet" href="../support/help.css" charset="ISO-8859-1" type="text/css" />
<title>E-Pharmacophores - Advanced Options Dialog Box</title>
</head>
<body>
<table bgcolor="#dcdcdc" border="0" cellspacing="0" width="100%">
<tr><td>
<p><img src="../images/common/schrodinger_logo.png" align="left" alt=""
 border="0" hspace="5" vspace="5" /></p>
</td></tr>
<tr><td>
<h1 class="title">E-Pharmacophores - Advanced Options Dialog Box</h1>
</td></tr>
</table>

<ul>
<li><a href="#summary">Summary</a></li>
<li><a href="#opening">Opening the <span class="GUI">E-Pharmacophores - Advanced Options</span> Dialog Box</a></li>
<li><a href="#features"><span class="GUI">E-Pharmacophores - Advanced Options</span> Dialog Box Features</a></li>
<li><a href="#links">Related Topics</a></li>
</ul>

<a name="summary"></a>
<h2>Summary</h2>

<p>Set options for the construction of the pharmacophore hypothesis. </p>

<a name="opening"></a>
<h2>Opening the E-Pharmacophores - Advanced Options Dialog Box</h2>

<p>To open the <span class="GUI">E-Pharmacophores - Advanced Options</span> dialog box, you can:</p>
<ul>
</ul>


<a name="features"></a> 
<h2>E-Pharmacophores - Advanced Options Dialog Box Features</h2> 

<ul>
<li><a href="#feature1"><span class="GUI">Definitions to use</span> options</a></li>
<li><a href="#feature2"><span class="GUI">Minimum feature-feature distance</span> box</a></li>
<li><a href="#feature3"><span class="GUI">Minimum feature-feature distance for features of the same type</span> box</a></li>
<li><a href="#feature4"><span class="GUI">Remove non-contributing fragments</span> option</a></li>
<li><a href="#feature5"><span class="GUI">Type of ligand efficiency normalization</span> options</a></li>
</ul>

<dl>

<a name="feature1"></a>
<dt><span class="GUI">Definitions to use</span> options</dt>
<dd><p>These options allow you to specify how to treat donor atoms and how the
pharmacophore features are defined. 
</p>
<ul>
<li><p><span class="GUI">Donors as vectors</span>&mdash;Treat donors as vector
features, in which the bond from the donor heavy atom to the hydrogen is treated
as a vector along which the acceptor must lie. This implies that the acceptor
can only form a hydrogen bond with a donor that lies along this vector.
</p></li>
<li><p><span class="GUI">Donors as projected points</span>&mdash;Treat a donor
as a point feature, located where the corresponding acceptor would be found in a
complex, here set to 1.4&Aring; from the H atom along the X-H bond. This implies
that the acceptor can accept a hydrogen bond with donors from other directions
and in other locations. For the purpose of developing a common pharmacophore
hypothesis, this choice allows matching of donors as belonging to the same
feature even if the donor atoms themselves are not in the same location, because
the corresponding acceptor is in the same locaction.
</p></li>
<li><p><span class="GUI">Custom feature file</span>&mdash;Specify the
pharmacophore feature set to use, by reading a custom feature file. 
Click <span class="GUI">Browse</span> to open a file selector, in which you can
navigate to the file and open it.
</p></li>

</ul>

</dd>

<a name="feature2"></a>
<dt><span class="GUI">Minimum feature-feature distance</span> box</dt>
<dd><p>Set the minimum allowed distance between any two distinct features. This
distance can be used to screen out features on atoms that are bonded to each
other, for example. 
</p></dd>

<a name="feature3"></a>
<dt><span class="GUI">Minimum feature-feature distance for features of the same type</span> box</dt>
<dd><p>Set the minimum allowed distance between any two distinct features that
have the same pharmacophore type (donor, acceptor, etc.).
</p></dd>

<a name="feature4"></a>
<dt><span class="GUI">Remove non-contributing fragments</span> option</dt>
<dd><p>Remove fragments that do not contribute to the hypothesis from ...
</p></dd>

<a name="feature5"></a>
<dt><span class="GUI">Type of ligand efficiency normalization</span> options</dt>
<dd><p>Specify the definition of ligand efficiency used to normalize the docking
score. Scores are compared after dividing by the chosen ligand efficiency value.
</p>
<ul>
<li><p><span class="GUI">None</span>&mdash;Don't use any ligand efficiency
normalization. 
</p></li>
<li><p><span class="GUI">Atom</span>&mdash;Use the number of heavy atoms to
normalize the scores. 
</p></li>
<li><p><span class="GUI">MW</span>&mdash;Use the molecular weight to normalize
the scores.
</p></li>
<li><p><span class="GUI">Natural log</span>&mdash;Use (1 + ln n_heavy) to
normalize the scores, where n_heavy is the number of heavy atoms. 
</p></li>
</ul>

</dd>

</dl>

<a name="links"></a>
<h2>Related Topics</h2>
<ul>

<li><a href="epharmacophores.html">E-Pharmacophores Panel</a></li>

</ul>
<hr />
<table width="100%">
<tr><td><p class="small"><a href="../support/legal_notice.html" target="LegalNoticeWindow">Legal Notice</a></p></td>
<td>
<table align="right">
<tr><td><p class="small">
File: phase/epharmacophores_options.html<br />
Last updated: 17 Nov 2014
</p></td></tr>
</table>
</td></tr>
</table>
</body>
</html>
